FindTrial
Sign In

Factors Influencing the Dosage of Hydromorphone for Patient-Controlled Intravenous Analgesia after Gynecological Surgeries: A Retrospective Analysis

Factors affecting the use of hydromorphone for patient-controlled intravenous analgesia after gynecological surgery: a retrospective analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096654
Enrollment
Unknown
Registered
2025-01-27
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

High dosage of hydromorphone group/ Non high dosage of hydromorphone group:none

Sponsors

Zhongshan Hospital(Xiamen), Fudan University,
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) undergoing elective gynecological surgery in Zhongshan Hospital from January 2021 to July 2024; 2) patients treated with hydromorphone for postoperative intravenous analgesia; 3) patients aged 18-80 years old who have signed the informed consent for the donation of biological samples and health-related information in our hospital.

Exclusion criteria

Exclusion criteria: 1) history of chronic pain and psychiatric disorders; 2) preoperative use of analgesics; 3) postoperative intensive care unit (ICU) transfer; 4) postoperative use of opioids other than hydromorphone. 5) incomplete data; 6) Stop the pump.

Design outcomes

Primary

MeasureTime frame
Hydromorphone consumption 48h after gynecological surgery;—

Secondary

MeasureTime frame
Adverse reactions;Demographic Factors;Surgical Factors;—

Countries

China

Contacts

Public ContactJingyi Wu

Zhongshan Hospital(Xiamen), Fudan University

wu.jingyi@zsxmhospital.com+86 138 0608 6472

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026